New therapy aims to help teens battling addiction and anxiety

NCT ID NCT01117753

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new behavioral therapy called OPT-A for teenagers who have both substance use problems and mood or anxiety disorders. 140 teens aged 10-17 will receive either OPT-A or standard treatment. Researchers will track substance use and mental health for 18 months to see if the new therapy works better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

OutPatient Treatment for Adolescents (OPT-A) - a behavioral therapy

What this could lead to

If successful, this could provide an effective treatment option for teens struggling with both substance use and mental health issues, improving their outcomes.

What could go wrong

This is a relatively small, early-stage trial (140 participants). The results may not apply to all teens, and the new therapy may not prove better than usual care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MOOD DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder depressive disorder mood disorder substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of South Carolina, Department of Psychiatry & Behavioral Sciences, Family Services Research Center

    Charleston, South Carolina, 29425, United States